(Q23913594)

0 references

Matthew Keifer

0 references

Clarence A. Broomfield

0 references

Jason Sowalla

0 references

Clement E. Furlong

Icahn School of Medicine at Mount Sinai

0 references

language of work or name

English

0 references

publication date

November 1996

0 references

0 references

0 references

0 references

334-336

0 references

performing organization

object named as

Mount Sinai School of Medicine

1 reference

NIOSHTIC-2

on focus list of Wikimedia project

2 February 2024

Wikimedia–NIOSH collaboration

0 references

1 reference

25 September 2023

Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

Organophosphate poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

Paraoxonase protects against chlorpyrifos toxicity in mice

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

Studies on the acute and long-term oral toxicity fo chlorpyrifos (0,0-diethyl-0(3,5,6-trichloro-2-pyridyl) phosphorothioate).

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

The influence of age on the toxicity and metabolism of methyl parathion and parathion in male and female rats

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1038%2FNG1196-334

7 January 2021